comparemela.com

Page 2 - Movellus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Maestro Clock Generation Module [PLL], 10x smaller than existing solutions

Maestro Adaptive Workload Manager [PLL] actively adapts to workload changes to boost silicon performance

Movellus to Provide Intelligent Clock Network IP to BAE Systems

Movellus CEO Mo Faisal to Present at Linley Fall Processor Conference

Brooklyn ImmunoTherapeutics Establishes Research and Development Center in Cambridge, Massachusetts

Co-locates with technology developers Factor Bioscience and Novellus TherapeuticsBROOKLYN, N.Y., June 02, 2021 (GLOBE NEWSWIRE) Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic disorders, today announced it has established a research and development center in Cambridge, Massachusetts, to pursue its m

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.